Latest Articles

Publication Date
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times

Published: Feb. 5, 2025, 1:07 p.m.
Acrivon's AI-Powered Cancer Test Achieves 62.5% Response Rate, Earns FDA Breakthrough Status - StockTitan

Acrivon's AI-Powered Cancer Test Achieves 62.5% Response Rate, Earns FDA Breakthrough Status StockTitan

Published: Feb. 5, 2025, 1 p.m.
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron - Nature.com

Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Nature.com

Published: Feb. 5, 2025, 11:37 a.m.
Cancer risk could increase by hot water bottle use, doctor warns - Gloucestershire Live

Cancer risk could increase by hot water bottle use, doctor warns Gloucestershire Live

Published: Feb. 4, 2025, 1:40 p.m.
Doctor issues urgent cancer warning over hot water bottles - don't do this - The Mirror

Doctor issues urgent cancer warning over hot water bottles - don't do this The Mirror

Published: Feb. 4, 2025, 1:31 p.m.
Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab - Physician's Weekly

Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab Physician's Weekly

Published: Feb. 4, 2025, 11:09 a.m.
Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program - AboutLawsuits.com

Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program AboutLawsuits.com

Published: Feb. 3, 2025, 9:15 p.m.
Endometrial Cancer and Mental Health: Challenges and Finding Support - Healthline

Endometrial Cancer and Mental Health: Challenges and Finding Support Healthline

Published: Feb. 3, 2025, 5:51 p.m.
(PDF) Radiotherapy improves stress urinary incontinence but impairs pelvic floor function in endometrial cancer patients: a prospective cohort study - ResearchGate

(PDF) Radiotherapy improves stress urinary incontinence but impairs pelvic floor function in endometrial cancer patients: a prospective cohort study ResearchGate

Published: Feb. 2, 2025, 4:08 a.m.
Retrospective Data Highlight FRα and B7-H4 As Potential ADC Targets in Endometrial Cancer - OncLive

Retrospective Data Highlight FRα and B7-H4 As Potential ADC Targets in Endometrial Cancer OncLive

Published: Feb. 1, 2025, 12:11 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!